374 related articles for article (PubMed ID: 12440952)
21. Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein.
Cao H; Tuttle JS; Blackshear PJ
J Biol Chem; 2004 May; 279(20):21489-99. PubMed ID: 15010466
[TBL] [Abstract][Full Text] [Related]
22. Phylogenetic distribution and evolution of the linked RNA-binding and NOT1-binding domains in the tristetraprolin family of tandem CCCH zinc finger proteins.
Blackshear PJ; Perera L
J Interferon Cytokine Res; 2014 Apr; 34(4):297-306. PubMed ID: 24697206
[TBL] [Abstract][Full Text] [Related]
23. Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells.
Suzuki E; Tsutsumi A; Goto D; Matsumoto I; Ito S; Otsu M; Onodera M; Takahashi S; Sato Y; Sumida T
Int J Mol Med; 2006 May; 17(5):801-9. PubMed ID: 16596264
[TBL] [Abstract][Full Text] [Related]
24. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of Au-rich MRNA-destabilizing motifs.
Brewer BY; Malicka J; Blackshear PJ; Wilson GM
J Biol Chem; 2004 Jul; 279(27):27870-7. PubMed ID: 15117938
[TBL] [Abstract][Full Text] [Related]
25. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.
Brooks SA; Connolly JE; Rigby WF
J Immunol; 2004 Jun; 172(12):7263-71. PubMed ID: 15187101
[TBL] [Abstract][Full Text] [Related]
26. Mutational and structural analysis of the tandem zinc finger domain of tristetraprolin.
Lai WS; Perera L; Hicks SN; Blackshear PJ
J Biol Chem; 2014 Jan; 289(1):565-80. PubMed ID: 24253039
[TBL] [Abstract][Full Text] [Related]
27. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.
Tchen CR; Brook M; Saklatvala J; Clark AR
J Biol Chem; 2004 Jul; 279(31):32393-400. PubMed ID: 15187092
[TBL] [Abstract][Full Text] [Related]
28. The tandem zinc finger RNA binding domain of members of the tristetraprolin protein family.
Lai WS; Wells ML; Perera L; Blackshear PJ
Wiley Interdiscip Rev RNA; 2019 Jul; 10(4):e1531. PubMed ID: 30864256
[TBL] [Abstract][Full Text] [Related]
29. Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.
Cao H
Biochemistry; 2004 Nov; 43(43):13724-38. PubMed ID: 15504035
[TBL] [Abstract][Full Text] [Related]
30. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway.
Carballo E; Cao H; Lai WS; Kennington EA; Campbell D; Blackshear PJ
J Biol Chem; 2001 Nov; 276(45):42580-7. PubMed ID: 11546803
[TBL] [Abstract][Full Text] [Related]
31. Salbutamol increases tristetraprolin expression in macrophages.
Jalonen U; Leppänen T; Kankaanranta H; Moilanen E
Life Sci; 2007 Dec; 81(25-26):1651-8. PubMed ID: 17964608
[TBL] [Abstract][Full Text] [Related]
32. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin.
Carballo E; Lai WS; Blackshear PJ
Science; 1998 Aug; 281(5379):1001-5. PubMed ID: 9703499
[TBL] [Abstract][Full Text] [Related]
33. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival.
Johnson BA; Geha M; Blackwell TK
Oncogene; 2000 Mar; 19(13):1657-64. PubMed ID: 10763822
[TBL] [Abstract][Full Text] [Related]
34. Backbone and sidechain
Hicks SN; Venters RA; Blackshear PJ
Biomol NMR Assign; 2022 Apr; 16(1):153-158. PubMed ID: 35279790
[TBL] [Abstract][Full Text] [Related]
35. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d.
Hudson BP; Martinez-Yamout MA; Dyson HJ; Wright PE
Nat Struct Mol Biol; 2004 Mar; 11(3):257-64. PubMed ID: 14981510
[TBL] [Abstract][Full Text] [Related]
36. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
Stoecklin G; Gross B; Ming XF; Moroni C
Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
[TBL] [Abstract][Full Text] [Related]
37. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.
Brooks SA; Blackshear PJ
Biochim Biophys Acta; 2013; 1829(6-7):666-79. PubMed ID: 23428348
[TBL] [Abstract][Full Text] [Related]
38. Tristetraprolin: A cytosolic regulator of mRNA turnover moonlighting as transcriptional corepressor of gene expression.
Rodríguez-Gómez G; Paredes-Villa A; Cervantes-Badillo MG; Gómez-Sonora JP; Jorge-Pérez JH; Cervantes-Roldán R; León-Del-Río A
Mol Genet Metab; 2021 Jun; 133(2):137-147. PubMed ID: 33795191
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin.
Stoecklin G; Tenenbaum SA; Mayo T; Chittur SV; George AD; Baroni TE; Blackshear PJ; Anderson P
J Biol Chem; 2008 Apr; 283(17):11689-99. PubMed ID: 18256032
[TBL] [Abstract][Full Text] [Related]
40. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.
Hau HH; Walsh RJ; Ogilvie RL; Williams DA; Reilly CS; Bohjanen PR
J Cell Biochem; 2007 Apr; 100(6):1477-92. PubMed ID: 17133347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
